IP Library Granted Patent US 9,643,912
Granted Patent B2
US 9,643,912 · App. 14/939,422 · Granted May 9, 2017

Fatty alcohol esters of hydroxycarboxylic acids

Inventors: Joseph P. St. Laurent (Lakeville, MA); Scott A. Goodrich (Stoughton, MA); Gerald S. Jones, Jr. (Norwood, MA)
Assignee: CHEMSMART, LLC
C07C69/68C08G65/3322C12P7/62C12Y301/01003C07B2200/07Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,643,912
App. No.
14/939,422
Granted
May 9, 2017
Kind
B2
Abstract

Described herein are compositions (e.g., a pharmaceutical composition) and compounds of formula I, methods of making compounds of formula (I) and their use in the treatment and/or prevention of diseases and disorders.

Claims (36)

1. A composition configured for topical administration, comprising a compound of formula (I):

wherein

R 1 is a C 12 alkyl;

n is an integer from 4 to 10; and

R 2 is hydrogen, alkyl, aryl, heteroaryl, or heterocyclyl;

or a pharmaceutically acceptable salt thereof.

2. The composition of claim 1 , wherein R 2 is alkyl.

3. The composition of claim 2 , wherein R 2 is C 1-4 alkyl.

4. The composition of claim 1 , wherein R 2 is aryl.

5. The composition of claim 1 , wherein when R 2 is not hydrogen, the compound of formula (I) is a racemic mixture of a compound of formula (I).

6. The composition of claim 1 , wherein when R 2 is not hydrogen, the compound of formula (I) is at least 90% enantiomeric excess of the R stereoisomer.

7. The composition of claim 1 , wherein when R 2 is not hydrogen, the compound of formula (I) is at least 90% enantiomeric excess of the S stereoisomer.

8. The composition of claim 1 , wherein the compound of formula (I) is represented by the following formula:

wherein n is 4.

9. The composition of claim 1 , wherein the compound of formula (I) is represented by the following formula:

wherein n is 4.

10. The composition of claim 1 , wherein the compound of formula (I) is represented by the following formula:

wherein n is 4.

11. The composition of claim 1 , wherein the composition is a gel.

12. A composition configured for topical administration, comprising a compound of formula (I):

wherein

R 1 is a C 8-35 alkyl;

n is an integer from 4 to 10; and

R 2 is hydrogen, alkyl, aryl, heteroaryl, or heterocyclyl;

or a pharmaceutically acceptable salt thereof.

13. The composition of claim 12 , wherein R 1 is a C 8-25 alkyl group.

14. The composition of claim 13 , wherein R 1 is a C 10-20 alkyl group.

15. The composition of claim 14 , wherein R 1 is a C 10-15 alkyl group.

16. The composition of claim 12 , wherein R 2 is alkyl.

17. The composition of claim 16 , wherein R 2 is C 1-4 alkyl.

18. The composition of claim 12 , wherein R 2 is aryl.

19. The composition of claim 16 , wherein R 2 is aralkyl.

20. The composition of claim 12 , wherein when R 2 is not hydrogen, the compound of formula (I) is a racemic mixture of a compound of formula (I).

21. The composition of claim 12 , wherein when R 2 is not hydrogen, the compound of formula (I) is at least 90% enantiomeric excess of the R stereoisomer.

22. The composition of claim 12 , wherein when R 2 is not hydrogen, the compound of formula (I) is at least 90% enantiomeric excess of the S stereoisomer.

23. The composition of claim 12 , wherein the composition is a gel.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2022
From: CHEMIC LABORATORIES, LLC
To: JSB PHARMA DEVELOPMENT, LLC
Reel/Frame 059266/0352 →
CHANGE OF NAME Recorded Mar 15, 2022
From: CHEMIC LABORATORIES, INC.
To: CHEMIC LABORATORIES, LLC
Reel/Frame 059365/0682 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2021
From: CHEMSMART, LLC
To: CHEMIC LABORATORIES, INC.
Reel/Frame 055204/0112 →
Continuity (3)
Continuation 13823406
Provisional Application 61383894 · Sep 17, 2010
Related Publication 20160060206A1 · Mar 3, 2016